Surgical treatment of XXXX .

@entity1 @entity712 @entity295 @entity886 @entity340 @entity884
From February, 1975 through October, 1990, 26 @entity1 underwent surgical treatment for @entity884 at Tokai University Hospital. The overall operative mortality rate was 11.5% (3/26). The three @entity1 who died were suffering from aortic @entity340 ( @entity340 ) in the active stage. Among 16 @entity1 in the active stage, the mortality rate was 18.7% (3/16) Among 10 @entity1 with @entity340 ( @entity340 ) in the healed stage, all survived. Among the total of 21 @entity1 with @entity340 , the mortality rate was zero and among those with @entity340 , the rate was 60% (3/5). Various species of streptococci were the most common organisms encountered, followed by Staphylococcus epidermides. The two @entity340 @entity1 with S. epidermides died. Nine of the 11 @entity340 cases in the active stage were of the localized type. Only one case of the localized type of @entity340 suffered from an infected mitral bioprosthetic valve. The 6 extensive-type cases had @entity886 (2NVE, 4PVE). Three @entity1 with the extensive type of @entity340 died. We conclude that @entity1 with @entity884 who develop progressive @entity712 , recurrent embolization, or progressive @entity295 despite antimicrobial treatments, should undergo prompt valve replacement within 7 days after institution of therapy.
